Brian L. Clevinger

Megan Health, Inc. developed human and animal vaccines using patented gene modification technologies. The company was headquartered in St. Louis, MO.

Neurolutions, Inc. develops revolutionary platform of devices, based on Brain Computer Interface (BCI) technology, which promise to restore function to patients who are disabled as a result of neurological injury. The company was founded by Eric Leuthhardt, Daniel J. Moran, and Gerwin Schalk on October 1, 2008 and is headquartered in St. Louis, MO.

AirXpanders, Inc. engaged in the design, manufacture, sale and distribution of medical devices. It offers AeroForm Tissue Expander System, a needle-free, patient-controlled tissue expander used in patients undergoing two-stage breast reconstruction following mastectomy prior to the insertion of a breast implant. The company was founded by Daniel I. Jacobs, Barry Cheskin, and Teddy Shalon on March 17, 2005 and was headquartered in San Jose, CA.

Chlorogen, Inc. develops plant-made drugs and vaccines for the treatment and prevention of human diseases. It provides several therapeutic proteins for high-mortality diseases of ovarian and pancreatic cancer. The company was founded by Henry Daniell in 2001 and is headquartered in St. Louis, MO

Travanti Pharma, Inc. designs, develops and markets drug delivery technology equipment and platform services. The company was founded in 1997 and is headquartered in Mendota Heights, MN.

APT Therapeutics, Inc. manufactures hospital equipment. Its products include X-ray equipment, tubes & related irradiation equipment, Medical X ray film illuminator screens, Medical X ray film transfer cases, Medical X ray film illuminator clips and more. The company was founded by Ridong Chen in 2001 and is headquartered in St. Louis, MO.

Altheus Therapeutics, Inc. developed novel therapies for inflammatory bowel diseases. It developed Zoenasa oral tablets and rectal gel formulations as novel front-line therapies for the treatment of ulcerative colitis and other inflammatory bowel diseases. The company was founded by William A. Hagstrom and Richard F. Harty in 2006 and was headquartered Oklahoma, OK.

ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI.

Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK.